A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

July 22, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

December 30, 2026

Conditions
Extensive Stage-small Cell Lung Cancer
Interventions
DRUG

Ifinatamab deruxtecan

Intravenous administration

DRUG

Atezolizumab

Intravenous administration

DRUG

Carboplatin

Intravenous administration

Trial Locations (58)

8035

NOT_YET_RECRUITING

Hospital Universitari Vall D'Hebron, Barcelona

10021

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10032

RECRUITING

Columbia University Hervert Irving Comprehensive Cancer Center, New York

10461

RECRUITING

Montefiore Medical Center, New York

11501

RECRUITING

New York University Cancer Center - Laura and Isaac Perlmutter Cancer Center At Nyu Langone, Mineola

RECRUITING

NYU Langone Hospital - Long Island, Mineola

13005

NOT_YET_RECRUITING

"Assistance Publique-HăPitaux de Marseille", Marseille

17007

NOT_YET_RECRUITING

Ico Girona - Hospital Universitari de Girona Dr Josep Trueta, Girona

17601

RECRUITING

Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster

19104

RECRUITING

University of Pennsylvania, Abramson Cancer Center, Philadelphia

19107

RECRUITING

Thomas Jefferson University Hospital - Central, Philadelphia

22031

RECRUITING

Next Virginia, Fairfax

28007

NOT_YET_RECRUITING

Hospital General Universitario Gregorio Marañon, Madrid

28034

NOT_YET_RECRUITING

Hospital Universitario Ramon Y Cajal, Madrid

28041

NOT_YET_RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28223

NOT_YET_RECRUITING

Next Madrid, Madrid

29010

NOT_YET_RECRUITING

Hospital Regional Universitario de Malaga, Málaga

32224

RECRUITING

Mayo Clinic-Jacksonville, Jacksonville

32804

RECRUITING

Advent Health Orlando, Orlando

33612

RECRUITING

Moffitt Cancer Center, Tampa

35000

NOT_YET_RECRUITING

Chu Rennes - Hopital Pontchaillou, Rennes

35233

RECRUITING

University of Alabama -Birmingham, Birmingham

36312

NOT_YET_RECRUITING

Hospital Alvaro Cunqueiro, Vigo

37203

RECRUITING

Scri Oncology Partners, Nashville

41009

NOT_YET_RECRUITING

Hospital Universitario Virgen Macarena, Seville

41013

NOT_YET_RECRUITING

Hospital Universitario Virgen Del Rocio, Seville

44805

NOT_YET_RECRUITING

"Chu Nantes - HăPital Guillaume Et Renă Laă<Nnec", Saint-Herblain

48202

RECRUITING

Henry Ford Hospital, Detroit

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

55455

RECRUITING

Regents of the University of Minnesota, Minneapolis

55905

RECRUITING

Mayo Clinic, Rochester

59037

NOT_YET_RECRUITING

Hopital Albert Calmette - Chu Lille, Lille

60611

RECRUITING

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

69008

NOT_YET_RECRUITING

Centre Léon Bérard, Lyon

75005

NOT_YET_RECRUITING

Institut Curie - Site de Paris, Paris

75020

NOT_YET_RECRUITING

Hopital Tenon, Paris

85054

RECRUITING

Mayo Clinic Arizona, Phoenix

90095

NOT_YET_RECRUITING

David Geffen School of Medicine, Los Angeles

92151

NOT_YET_RECRUITING

"HăPital Foch", Suresnes

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

94805

NOT_YET_RECRUITING

Institut Gustave Roussy, Villejuif

98684

RECRUITING

Northwest Cancer Specialists, P.C.-Vancouver, Vancouver

03766

RECRUITING

Dartmouth-Hitchcock Medical Center, Lebanon

08816

RECRUITING

Astera Cancer Care, East Brunswick

07601

RECRUITING

John Theurer Cancer Center At Hackensack Umc, Hackensack

670-8520

RECRUITING

NHO Himeji Medical Center, Himeji-shi

573-1191

RECRUITING

Kansai Medical University Hospital, Hirakata-shi

277-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa

135-8550

RECRUITING

The Cancer Institute Hospital of Jfcr, Kōtoku

861-4193

RECRUITING

Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc. Saiseikai Kumamoto Hospital, Kumamoto

411-8777

RECRUITING

Shizuoka Cancer Center, Nagaizumi-cho

951-8566

RECRUITING

Niigata Cancer Center Hospital, Niigata

700-8558

RECRUITING

Okayama University Hospital, Okayama

589-8511

RECRUITING

Kindai University Hospital, Ōsaka-sayama

770-8503

RECRUITING

Tokushima University Hospital, Tokushima

470-1192

RECRUITING

Fujita Health University Hospital, Toyoake-shi

08036

NOT_YET_RECRUITING

Hospital Clinic de Barcelona, Barcelona

08908

NOT_YET_RECRUITING

Ico L'Hospitalet - Hospital Duran I Reynals, L'Hospitalet de Llobregat

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Daiichi Sankyo

INDUSTRY

NCT06362252 - A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) | Biotech Hunter | Biotech Hunter